期刊文献+

结直肠癌患者血清中血管内皮生长因子的水平及其意义 被引量:3

Serum Vascular Endothelial Growth Factor Levels in Patients with Primary Colorectal Carcinoma and its Significance
原文传递
导出
摘要 目的:测定结直肠癌患者血清血管内皮生长因子(VEGF)的含量,分析其与临床病理指标间的关系。方法:采用ELISA法测定42例初治结直肠癌患者血清VEGF含量,正常对照30例。结果:结直肠癌患者血清VEGF浓度为274.21±218.38 pg/ml,明显高于正常对照组浓度(169.06±68.01 pg/ml,P<0.02),结肠癌患者血清VEGF浓度为346.52±168.57 pg/ml明显高于直肠癌患者(237.31±124.10 pg/ml,P<0.05)。Dukes B、C、D期组患者血清VEGF浓度与对照组相比均有明显差异(P<0.05),Dukes D期组与Dukes A、B、C期组亦均有明显差异(P<0.05)。结直肠癌患者血清VEGF浓度与年龄、性别无相关性(P>0.05)。结论:VEGF与结直肠癌的发生发展及癌肿部位有关,对探讨结直肠癌的发生机制,病情判断,预后及指导治疗有一定价值,对早期诊断似无帮助。 Objective:To detemine the correlation between serum vascular endothelial growth factor (VEGF) and clinical pathologic features in pre-treated patients with coloreetal carcinoma, Methods:Serum VEGF was measured by Enzyme-linked immunosorbent assay (ELJSA) in 30 healthy controls and 42 pretreated patients with coloreetal carcinoma. Results: Serum VEGF was significantly elevated in patients with primary coloreetal carcinoma in contrast to controls. Patients with the primary tumour localized in the colon had significantly ( P < 0.05) higher levels of VEGF than patients with the primary tumour localized in the rectum. Patients with Dukes stage B, C and D disease had significantly ( P < 0.05) higher levels of VEGF than controls. Patients with Dukes stage D disease had significantly ( P < 0.05) higher values than patients with Dukes stage A, B and C .There were no significant correlation among gender, age with serum VEGF ( P > 0.05). Conclusion: Serum VEGF was associated with the development, metostasis and location of coloreetal carcinoma. It can be used as important references in the therapeutic effect and prognosis. It is not a useful marker for diagnosis of early coloreetal carcinoma.
作者 张亚武
出处 《临床消化病杂志》 2004年第4期163-164,共2页 Chinese Journal of Clinical Gastroenterology
关键词 结直肠癌 血管内皮生长因子 血清 Colorectal carcinoma Vascular endothelial growth factor Serum
  • 相关文献

参考文献7

  • 1Karayiannkis AJ, Syrigns KN, Zbar A, et al, Clinical significance of prenperative serum vascular endothelial growth factor levels in patients with coloreetal cancer and the effect of tumor surgery[J].Surgery,2002,131: 548.
  • 2Folkman J, Watson K, Ingber D, et al, Induction of angiogenesis during the transition fron hyperplasia to neoplasia[J], Nature, 1989,339:58.
  • 3Kraft A,Weindel K, OchsA,etal. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease[J].Cancer, 1998,85,178.
  • 4Kumar H, Heer K,Lee PW, et al. Preoperative serum vascular endothelial growth factor can predict stag in colorectal cancer[J]. clin Cancer Res,1998,4(5): 1279.
  • 5Landriscina M,Cassano A, Ratto C,et al. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorcetal cancer[J]. Br J Cancer, 1998,78:765.
  • 6Lee JC, Chow NH,Wang ST, et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients [J]. Eor J Cancer,2000,36:748.
  • 7Broll R,Erdmann H,Duchrow M,et al. Vascullar endothelial 'growth factor (VEGF)-α valuable serum tumour marker in patients with colorectal cancer [J]? EurJ Surg Oncol,2001,27:37.

同被引文献38

  • 1杨业洲,梅立,胡家骆,董巍,杨年.子宫肌瘤患者外周静脉与子宫静脉血管内皮细胞生长因子水平测定及临床意义[J].实用妇产科杂志,2005,21(7):411-412. 被引量:4
  • 2何立丽,张伟京,苏航,徐东刚.Ang-2与VEGF的协同作用及其在抗肿瘤血管新生治疗中的应用[J].中国实验血液学杂志,2007,15(2):445-448. 被引量:12
  • 3Hague' S, Zhang L, Oehler MK, et al. Expression of the hypoxicallyregulated angiogenic factor adrenomedullin correlates with uterineleiomyoma vascular density. Clin Cancer Res, 2000,6: 2808-2814.
  • 4Hu Q, Dey AL, Yang Y, et al. Soluble vascular endothelialgrowthfactor receptorl, and not receptor2, is an in'dependent prognesticfactor in acute myeloid leukemia and myelodysplastic Syndromes. Cancer, 2004,100:1884-1891.
  • 5Shimoyama S, Kaminishi M. Increased angiogenin expression in gastric cacer corrwlatwd with cancwr progression. Cancer Res Clin Oncol, 2000,126: 468- 474.
  • 6Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature, 2000,407: 249-257,
  • 7Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specificgrowth factors and blood vessel formation. Nature, 2000,407 : 242-248.
  • 8Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specificgrowth factors and blood vessel formation. Nature,2000, 407:242-248.
  • 9Hartman GD, Fraley ME,Bilodeau Mr. Kinase insertdomain-containing receptor kinase inhibitors as antiangiogenie' agents. Expert Opin Investig Drugs,2002,11 :737-745.
  • 10Ahmad SA, Liu W, Jung YD, et al. Differential expression ofangiopoietin-I and angiopoietin-2 in colon carcinoma. Cancer, 2001,92:1138-1143.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部